What is Qscreen Ai Inc. (PMEDF) stock price today?

Qscreen Ai Inc. (PMEDF) is currently trading at $0.02, up 0% today.

What is PMEDF P/E ratio?

Qscreen Ai Inc.'s P/E ratio is -13.10. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is PMEDF return on equity (ROE)?

Qscreen Ai Inc.'s return on equity (ROE) is 92.96%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is Qscreen Ai Inc.'s market cap?

Qscreen Ai Inc. has a market capitalization of $4.60M.

OTC · Medical - Devices

Qscreen Ai Inc. (PMEDF) Stock

$0.02 +0.00% OTC: PMEDF Healthcare

QScreen AI, Inc. is a life sciences technology firm that specializes in pioneering artificial intelligence (AI) solutions.

Valuation

Metric	Value
Price	$0.02
Market Cap	$4.60M
P/E Ratio	-13.10
P/B Ratio	-13.38
P/S Ratio	0.00
EPS (TTM)	$-0.01
52-Week High	$0.07
52-Week Low	$0.01
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	92.96%
ROA	-159.57%
ROCE	97.98%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.00
Current Ratio	0.34

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-2.0M	$-2.0M	$-2.0M	$-1.0M	$-1.0M
Net Profit	$-2.0M	$-2.0M	$-2.0M	$-1.0M	$-1.0M
EPS	$-0.02	$-0.02	$-0.01	$-0.01	$-0.01
Op Margin	-4718.3%	-5896.3%	—	—	—

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$1.0M	$1.0M	$0	$0	$1.0M
Total Liabilities	$1.0M	$1.0M	$1.0M	$1.0M	$1.0M
Cash	$0	$0	$0	$0	$0
Borrowings	$0	$0	$0	$0	$0

Latest News

QScreen AI Deepens US Institutional Pipeline as Screening Platform Adds Escalation-Based Review Capability TMX Newsfile · Jul 20, 2026 QScreen AI Secures Second US Patent Covering Core Impairment-Detection Method MT Newswires · Jul 14, 2026 QScreen AI Secures Second US Patent, Extending Single-Camera Impairment Detection on Standard Hardware TMX Newsfile · Jul 14, 2026 QScreen AI Announces Adoption of Semi-Annual Reporting TMX Newsfile · Jun 26, 2026 QScreen AI Up 12% as it Raises C$243,820 After Closing First Tranche of Private Placement MT Newswires · Jun 25, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-1.0M	$-1.0M	$-2.0M	$0	$-1.0M
Investing Cash Flow	$-1.0M	$0	$0	$0	$0
Financing Cash Flow	$1.0M	$0	$2.0M	$0	$0
Net Cash Flow	$0	$0	$0	$0	$0
Free Cash Flow	$-1.0M	$-1.0M	$-2.0M	$0	$-1.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-1.58
EV / EBITDA	-14.21
FCF Yield	-6.69%
Quick Ratio	0.34
Interest Coverage	0.00
Return 1Y	23.53%
Return 3Y	-72.37%
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ADMTADM Tronics Unlimited, Inc.	$0.04	-6.12%	-25.03	$2.54M	0.00%
BICXBioCorRx Inc.	$0.30	+0.00%	-1.80	$6.26M	0.00%
BIELBioelectronics Corporation	$0.00	—	—	$7.41M	0.00%
BUDZWEED, Inc.	$0.02	-10.69%	-2.35	$2.97M	0.00%
FZMDFuse Medical, Inc.	$0.02	-31.27%	10.00	$1.48M	0.00%

About Qscreen Ai Inc.

QScreen AI, Inc. is a life sciences technology firm that specializes in pioneering artificial intelligence (AI) solutions. These innovative technologies are designed to enhance general workplace health and safety, and to serve the wider healthcare industry. The company also furnishes specialized tools for medical practitioners. Established on September 3, 1987, its principal operations are based in Toronto, Canada.

Qscreen Ai Inc. is headquartered in CA.

Qscreen Ai Inc. (PMEDF) stock trades at $0.02 with a market capitalization of $4.60M. The stock is valued at a price-to-earnings (P/E) ratio of -13.10, price-to-book of -13.38, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.01 and $0.07, and currently trades 71.4% below its 52-week high.

On profitability, Qscreen Ai Inc. generates a return on equity (ROE) of 92.96% — well above the market average, a sign of a high-quality business, return on capital employed of 97.98%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: q-screen.ai

Related Healthcare Stocks

LLY Eli Lilly and Company $1182.62 +0.28% JNJ Johnson & Johnson $263.73 +0.88% ABBV AbbVie Inc. $281.04 +1.65% MRK Merck & Company, Inc. Common Stock (new) $145.45 -0.10% UNH UnitedHealth Group Incorporated Common Stock (DE) $378.52 -0.21% NVS Novartis AG $143.84 +0.06% AZN AstraZeneca PLC $158.33 -0.55% TMO Thermo Fisher Scientific Inc $662.24 +0.64% AMGN Amgen Inc. $417.57 +0.65% GILD Gilead Sciences, Inc. $150.43 -0.49% ABT Abbott Laboratories $101.82 +2.23% NVO Novo Nordisk A/S $38.58 -0.16%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides